Review



monoclonal anti-human/anti-mouse c5a antibodies  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    R&D Systems monoclonal anti-human/anti-mouse c5a antibodies
    Monoclonal Anti Human/Anti Mouse C5a Antibodies, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+monoclonal+anti+human+c5a/anti+human+c5a+antibody/us09937206-100-1-9
    Average 90 stars, based on 1 article reviews
    monoclonal anti-human/anti-mouse c5a antibodies - by Bioz Stars, 2026-10
    90/100 stars

    Images

    Related Articles

    Enzyme-linked Immunosorbent Assay:

    Article Title: C3, C5, and factor B bind to chitosan without complement activation.
    Article Snippet: Chitosan is a polycationic and biocompatible polysaccharide composed of glucosamine and N-acetyl glucosamine that is chemotactic for neutrophils and stimulates wound repair through mechanisms that remain unclear.. It was previously shown that chitosan depletes complement proteins from plasma, suggesting that chitosan activates complement.. Complement activation leads to cleavage of C5 to produce C5a, a neutrophil chemotactic factor.

    Incubation:

    Article Title: C3, C5, and factor B bind to chitosan without complement activation.
    Article Snippet: Chitosan is a polycationic and biocompatible polysaccharide composed of glucosamine and N-acetyl glucosamine that is chemotactic for neutrophils and stimulates wound repair through mechanisms that remain unclear.. It was previously shown that chitosan depletes complement proteins from plasma, suggesting that chitosan activates complement.. Complement activation leads to cleavage of C5 to produce C5a, a neutrophil chemotactic factor.

    Comparison:

    Article Title: C3, C5, and factor B bind to chitosan without complement activation.
    Article Snippet: Chitosan is a polycationic and biocompatible polysaccharide composed of glucosamine and N-acetyl glucosamine that is chemotactic for neutrophils and stimulates wound repair through mechanisms that remain unclear.. It was previously shown that chitosan depletes complement proteins from plasma, suggesting that chitosan activates complement.. Complement activation leads to cleavage of C5 to produce C5a, a neutrophil chemotactic factor.

    Control:

    Article Title: C3, C5, and factor B bind to chitosan without complement activation.
    Article Snippet: Chitosan is a polycationic and biocompatible polysaccharide composed of glucosamine and N-acetyl glucosamine that is chemotactic for neutrophils and stimulates wound repair through mechanisms that remain unclear.. It was previously shown that chitosan depletes complement proteins from plasma, suggesting that chitosan activates complement.. Complement activation leads to cleavage of C5 to produce C5a, a neutrophil chemotactic factor.

    Clinical Proteomics:

    Article Title: C3, C5, and factor B bind to chitosan without complement activation.
    Article Snippet: Chitosan is a polycationic and biocompatible polysaccharide composed of glucosamine and N-acetyl glucosamine that is chemotactic for neutrophils and stimulates wound repair through mechanisms that remain unclear.. It was previously shown that chitosan depletes complement proteins from plasma, suggesting that chitosan activates complement.. Complement activation leads to cleavage of C5 to produce C5a, a neutrophil chemotactic factor.

    Activation Assay:

    Article Title: C3, C5, and factor B bind to chitosan without complement activation.
    Article Snippet: Chitosan is a polycationic and biocompatible polysaccharide composed of glucosamine and N-acetyl glucosamine that is chemotactic for neutrophils and stimulates wound repair through mechanisms that remain unclear.. It was previously shown that chitosan depletes complement proteins from plasma, suggesting that chitosan activates complement.. Complement activation leads to cleavage of C5 to produce C5a, a neutrophil chemotactic factor.

    SDS Page:

    Article Title: C3, C5, and factor B bind to chitosan without complement activation.
    Article Snippet: Chitosan is a polycationic and biocompatible polysaccharide composed of glucosamine and N-acetyl glucosamine that is chemotactic for neutrophils and stimulates wound repair through mechanisms that remain unclear.. It was previously shown that chitosan depletes complement proteins from plasma, suggesting that chitosan activates complement.. Complement activation leads to cleavage of C5 to produce C5a, a neutrophil chemotactic factor.

    High Molecular Weight:

    Article Title: C3, C5, and factor B bind to chitosan without complement activation.
    Article Snippet: Chitosan is a polycationic and biocompatible polysaccharide composed of glucosamine and N-acetyl glucosamine that is chemotactic for neutrophils and stimulates wound repair through mechanisms that remain unclear.. It was previously shown that chitosan depletes complement proteins from plasma, suggesting that chitosan activates complement.. Complement activation leads to cleavage of C5 to produce C5a, a neutrophil chemotactic factor.

    Generated:

    Article Title: C3, C5, and factor B bind to chitosan without complement activation.
    Article Snippet: Chitosan is a polycationic and biocompatible polysaccharide composed of glucosamine and N-acetyl glucosamine that is chemotactic for neutrophils and stimulates wound repair through mechanisms that remain unclear.. It was previously shown that chitosan depletes complement proteins from plasma, suggesting that chitosan activates complement.. Complement activation leads to cleavage of C5 to produce C5a, a neutrophil chemotactic factor.

    Positive Control:

    Article Title: C3, C5, and factor B bind to chitosan without complement activation.
    Article Snippet: Chitosan is a polycationic and biocompatible polysaccharide composed of glucosamine and N-acetyl glucosamine that is chemotactic for neutrophils and stimulates wound repair through mechanisms that remain unclear.. It was previously shown that chitosan depletes complement proteins from plasma, suggesting that chitosan activates complement.. Complement activation leads to cleavage of C5 to produce C5a, a neutrophil chemotactic factor.



    Similar Products

    93
    Hycult Biotech mouse monoclonal anti human c5a c5a des arg antibody
    The co-expression of C5AR1 and its ligand <t>C5a</t> in intracranial aneurysm lesions. Specimens of intracranial aneurysm (IA) lesions (Aneurysm) or control arterial walls (Superficial temporal artery in ( A ), Anterior cerebral artery-olfactory artery bifurcation in ( B )) from human cases ( A ) or rats ( B ) were harvested and examined in immunohistochemistry. The representative images of immunofluorescent staining of IA lesions for C5AR1 (green), C5a/C5a des-arg (red in ( A )), C5 (red in ( B )), and merged images with nuclear staining by DAPI (blue) are shown. A demagnified image of lower panels in ( B ) is shown on the right. The square in the demagnified image corresponds to the area shown in the magnified images. Scale bar: 50 μm.
    Mouse Monoclonal Anti Human C5a C5a Des Arg Antibody, supplied by Hycult Biotech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+monoclonal+anti+human+c5a/C5a%2FC5a+des+Arg%2C+Human%2C+mAb+2952/pmc10850553-54-12-21
    Average 93 stars, based on 1 article reviews
    mouse monoclonal anti human c5a c5a des arg antibody - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    90
    R&D Systems monoclonal anti-human/anti-mouse c5a antibodies
    The co-expression of C5AR1 and its ligand <t>C5a</t> in intracranial aneurysm lesions. Specimens of intracranial aneurysm (IA) lesions (Aneurysm) or control arterial walls (Superficial temporal artery in ( A ), Anterior cerebral artery-olfactory artery bifurcation in ( B )) from human cases ( A ) or rats ( B ) were harvested and examined in immunohistochemistry. The representative images of immunofluorescent staining of IA lesions for C5AR1 (green), C5a/C5a des-arg (red in ( A )), C5 (red in ( B )), and merged images with nuclear staining by DAPI (blue) are shown. A demagnified image of lower panels in ( B ) is shown on the right. The square in the demagnified image corresponds to the area shown in the magnified images. Scale bar: 50 μm.
    Monoclonal Anti Human/Anti Mouse C5a Antibodies, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+monoclonal+anti+human+c5a/anti+human+c5a+antibody/us09937206-100-1-9
    Average 90 stars, based on 1 article reviews
    monoclonal anti-human/anti-mouse c5a antibodies - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    91
    R&D Systems biotinylated mouse monoclonal anti human c5a
    The co-expression of C5AR1 and its ligand <t>C5a</t> in intracranial aneurysm lesions. Specimens of intracranial aneurysm (IA) lesions (Aneurysm) or control arterial walls (Superficial temporal artery in ( A ), Anterior cerebral artery-olfactory artery bifurcation in ( B )) from human cases ( A ) or rats ( B ) were harvested and examined in immunohistochemistry. The representative images of immunofluorescent staining of IA lesions for C5AR1 (green), C5a/C5a des-arg (red in ( A )), C5 (red in ( B )), and merged images with nuclear staining by DAPI (blue) are shown. A demagnified image of lower panels in ( B ) is shown on the right. The square in the demagnified image corresponds to the area shown in the magnified images. Scale bar: 50 μm.
    Biotinylated Mouse Monoclonal Anti Human C5a, supplied by R&D Systems, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+monoclonal+anti+human+c5a/Human+Complement+Component+C5%2FC5a+Biotinylated+Antibody/pmc04282830-142-15-22
    Average 91 stars, based on 1 article reviews
    biotinylated mouse monoclonal anti human c5a - by Bioz Stars, 2026-10
    91/100 stars
      Buy from Supplier

    90
    R&D Systems mouse monoclonal anti human c5a
    The co-expression of C5AR1 and its ligand <t>C5a</t> in intracranial aneurysm lesions. Specimens of intracranial aneurysm (IA) lesions (Aneurysm) or control arterial walls (Superficial temporal artery in ( A ), Anterior cerebral artery-olfactory artery bifurcation in ( B )) from human cases ( A ) or rats ( B ) were harvested and examined in immunohistochemistry. The representative images of immunofluorescent staining of IA lesions for C5AR1 (green), C5a/C5a des-arg (red in ( A )), C5 (red in ( B )), and merged images with nuclear staining by DAPI (blue) are shown. A demagnified image of lower panels in ( B ) is shown on the right. The square in the demagnified image corresponds to the area shown in the magnified images. Scale bar: 50 μm.
    Mouse Monoclonal Anti Human C5a, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+monoclonal+anti+human+c5a/Human+Complement+Component+C5%2FC5a+Antibody/pmc04282830-139-11-17
    Average 90 stars, based on 1 article reviews
    mouse monoclonal anti human c5a - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    Image Search Results


    The co-expression of C5AR1 and its ligand C5a in intracranial aneurysm lesions. Specimens of intracranial aneurysm (IA) lesions (Aneurysm) or control arterial walls (Superficial temporal artery in ( A ), Anterior cerebral artery-olfactory artery bifurcation in ( B )) from human cases ( A ) or rats ( B ) were harvested and examined in immunohistochemistry. The representative images of immunofluorescent staining of IA lesions for C5AR1 (green), C5a/C5a des-arg (red in ( A )), C5 (red in ( B )), and merged images with nuclear staining by DAPI (blue) are shown. A demagnified image of lower panels in ( B ) is shown on the right. The square in the demagnified image corresponds to the area shown in the magnified images. Scale bar: 50 μm.

    Journal: Scientific Reports

    Article Title: C5a–C5AR1 axis as a potential trigger of the rupture of intracranial aneurysms

    doi: 10.1038/s41598-024-53651-7

    Figure Lengend Snippet: The co-expression of C5AR1 and its ligand C5a in intracranial aneurysm lesions. Specimens of intracranial aneurysm (IA) lesions (Aneurysm) or control arterial walls (Superficial temporal artery in ( A ), Anterior cerebral artery-olfactory artery bifurcation in ( B )) from human cases ( A ) or rats ( B ) were harvested and examined in immunohistochemistry. The representative images of immunofluorescent staining of IA lesions for C5AR1 (green), C5a/C5a des-arg (red in ( A )), C5 (red in ( B )), and merged images with nuclear staining by DAPI (blue) are shown. A demagnified image of lower panels in ( B ) is shown on the right. The square in the demagnified image corresponds to the area shown in the magnified images. Scale bar: 50 μm.

    Article Snippet: The incubation mixture was then subjected to a western blot analysis using mouse monoclonal anti-human C5a/C5a des-Arg antibody (clone 2952, #HM2079, Hycult Biotech).

    Techniques: Expressing, Control, Immunohistochemistry, Staining

    Tissue-type Plasminogen Activator as an up-stream factor to produce C5a from C5. ( A ) The expression of tissue-type Plasminogen Activator (tPA) and Plasminogen in intracranial aneurysm (IA) lesions. IA lesions from human cases or induced in rats were harvested subjected to immunohistochemical analyses. The images of immunofluorescent staining of IA lesions for tPA (green), Plasminogen (red), and merged images with nuclear staining by DAPI (blue) are shown. Scale bar: 50 μm. ( B ) Co-expression of tPA with C5a in IA lesions. Human IA lesions were harvested subjected to immunohistochemical analyses. The images of immunofluorescent staining of IA lesions for C5a/C5a des-arg which is the derivative of C5a (green), tPA (red), and merged images with nuclear staining by DAPI (blue) are shown. Scale bar: 50 μm. ( C ) Enzymatic cleavage of C5 into C5a by Plasmin. Recombinant C5 (100 μg/ml) was co-incubated with each dose of recombinant Plasmin as indicated (0–100 μg/ml) for 1.5 h in a cell-free system. The incubation mixture was subjected to western blot analyses. The representative images from the western blot analyses to detect C5 or C5a are shown. M; size marker. ( D ) The alternation in the coagulation-fibrinolysis system in IA lesions of rats. The heat map of genes related with the coagulation-fibrinolysis system from the comprehensive gene expression profile data set (GEO accession: GSE161044) is shown.

    Journal: Scientific Reports

    Article Title: C5a–C5AR1 axis as a potential trigger of the rupture of intracranial aneurysms

    doi: 10.1038/s41598-024-53651-7

    Figure Lengend Snippet: Tissue-type Plasminogen Activator as an up-stream factor to produce C5a from C5. ( A ) The expression of tissue-type Plasminogen Activator (tPA) and Plasminogen in intracranial aneurysm (IA) lesions. IA lesions from human cases or induced in rats were harvested subjected to immunohistochemical analyses. The images of immunofluorescent staining of IA lesions for tPA (green), Plasminogen (red), and merged images with nuclear staining by DAPI (blue) are shown. Scale bar: 50 μm. ( B ) Co-expression of tPA with C5a in IA lesions. Human IA lesions were harvested subjected to immunohistochemical analyses. The images of immunofluorescent staining of IA lesions for C5a/C5a des-arg which is the derivative of C5a (green), tPA (red), and merged images with nuclear staining by DAPI (blue) are shown. Scale bar: 50 μm. ( C ) Enzymatic cleavage of C5 into C5a by Plasmin. Recombinant C5 (100 μg/ml) was co-incubated with each dose of recombinant Plasmin as indicated (0–100 μg/ml) for 1.5 h in a cell-free system. The incubation mixture was subjected to western blot analyses. The representative images from the western blot analyses to detect C5 or C5a are shown. M; size marker. ( D ) The alternation in the coagulation-fibrinolysis system in IA lesions of rats. The heat map of genes related with the coagulation-fibrinolysis system from the comprehensive gene expression profile data set (GEO accession: GSE161044) is shown.

    Article Snippet: The incubation mixture was then subjected to a western blot analysis using mouse monoclonal anti-human C5a/C5a des-Arg antibody (clone 2952, #HM2079, Hycult Biotech).

    Techniques: Expressing, Immunohistochemical staining, Staining, Recombinant, Incubation, Western Blot, Marker, Coagulation

    C5a–C5AR1 signaling cascade-dependent induction of pro-inflammatory factors. ( A – C ) The C5a–C5AR1 signaling cascade-dependent induction of pro-inflammatory genes in phorbol myristate acetate-primed cell line from human case with diffuse histiocytic lymphoma, U937 cell line. Cells were treated with recombinant C5a as indicated in the panels (0–10 h in ( A ), 0–100 nM in ( B ), 10 nM and 10 h in ( C ). Some cells were pre-treated with the selective C5AR1 inhibitor, W54011 (300 nM, 30 min) prior to the treatment with recombinant C5a. Total RNA was then purified from treated cells subjected to quantitative RT-PCR analyses to examine the induction of TNF (a gene for TNF-α), IL1B or PTGS2 (a gene for COX-2; cyclooxygenase-2). Data represents as mean ± s.e.m (( A ), n = 4; ( B , C ), n = 6). Statistical analysis was done by the Wilcoxon rank sum test in ( A ), the Kruskal–Wallis test followed by the Steel–Dwass test in ( B , C ). *p < 0.05. ( D ) Co-expression of C5a with pro-inflammatory factors in intracranial aneurysm (IA) lesions. IA lesions induced in rats were harvested subjected to immunohistochemical analyses. The images of immunofluorescent staining of IA lesions for C5ar1 (green), TNF-α (red), IL-1β (red), COX-2 (red), and merged images with nuclear staining by DAPI (blue) are shown. Scale bar: 50 μm.

    Journal: Scientific Reports

    Article Title: C5a–C5AR1 axis as a potential trigger of the rupture of intracranial aneurysms

    doi: 10.1038/s41598-024-53651-7

    Figure Lengend Snippet: C5a–C5AR1 signaling cascade-dependent induction of pro-inflammatory factors. ( A – C ) The C5a–C5AR1 signaling cascade-dependent induction of pro-inflammatory genes in phorbol myristate acetate-primed cell line from human case with diffuse histiocytic lymphoma, U937 cell line. Cells were treated with recombinant C5a as indicated in the panels (0–10 h in ( A ), 0–100 nM in ( B ), 10 nM and 10 h in ( C ). Some cells were pre-treated with the selective C5AR1 inhibitor, W54011 (300 nM, 30 min) prior to the treatment with recombinant C5a. Total RNA was then purified from treated cells subjected to quantitative RT-PCR analyses to examine the induction of TNF (a gene for TNF-α), IL1B or PTGS2 (a gene for COX-2; cyclooxygenase-2). Data represents as mean ± s.e.m (( A ), n = 4; ( B , C ), n = 6). Statistical analysis was done by the Wilcoxon rank sum test in ( A ), the Kruskal–Wallis test followed by the Steel–Dwass test in ( B , C ). *p < 0.05. ( D ) Co-expression of C5a with pro-inflammatory factors in intracranial aneurysm (IA) lesions. IA lesions induced in rats were harvested subjected to immunohistochemical analyses. The images of immunofluorescent staining of IA lesions for C5ar1 (green), TNF-α (red), IL-1β (red), COX-2 (red), and merged images with nuclear staining by DAPI (blue) are shown. Scale bar: 50 μm.

    Article Snippet: The incubation mixture was then subjected to a western blot analysis using mouse monoclonal anti-human C5a/C5a des-Arg antibody (clone 2952, #HM2079, Hycult Biotech).

    Techniques: Recombinant, Purification, Quantitative RT-PCR, Expressing, Immunohistochemical staining, Staining